External validation of two web-based postoperative nomograms predicting the probability of early biochemical recurrence after radical prostatectomy: a retrospective cohort study

被引:9
作者
Yoneda, Kei [1 ]
Utsumi, Takanobu [1 ,2 ]
Somoto, Takatoshi [1 ]
Wakai, Ken [1 ]
Oka, Ryo [1 ]
Endo, Takumi [1 ]
Yano, Masashi [1 ]
Kamiya, Naoto [1 ]
Hiruta, Nobuyuki [3 ]
Suzuki, Hiroyoshi [1 ]
机构
[1] Toho Univ, Sakura Med Ctr, Dept Urol, 564-1 Shimoshizu, Sakura, Chiba 2858741, Japan
[2] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] Toho Univ, Sakura Med Ctr, Dept Surg Pathol, Chiba, Japan
关键词
prostate cancer; radical prostatectomy; biochemical recurrence; nomogram; LYMPHATIC VESSEL DENSITY; LYMPHOVASCULAR INVASION; ANTIGEN RECURRENCE; FOLLOW-UP; CANCER; RISK; BIOPSY; PROGRESSION; SPECIMENS; RADIOTHERAPY;
D O I
10.1093/jjco/hyx174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to validate and compare the predictive accuracies of the Memorial Sloan Kettering Cancer Center (MSKCC) and Johns Hopkins University (JHU) web-based postoperative nomograms for predicting early biochemical recurrence (BCR) after radical prostatectomy (RP) and to analyze clinicopathological factors to predict early BCR after RP using our dataset. The c-index was 0.72 (95% confidence (CI): 0.61-0.83) for the MSKCC nomogram and 0.71 (95% CI: 0.61-0.81) for the and JHU nomogram, demonstrating fair performance in the Japanese population. Furthermore, we statistically analyzed our 174 patients to elucidate prognostic factors for early BCR within 2 years. Lymphovascular invasion (LVI) including lymphatic vessel invasion (ly) was a significant predictor of early BCR in addition to common variables (pT stage, extraprostatic extension, positive surgical margin and seminal vesicle invasion). LVI, particularly ly, may provide a good predictor of early BCR after RP and improve the accuracy of the nomograms.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 31 条
[1]  
[Anonymous], UROL ONCOL SEMIN ORI
[2]   Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) [J].
Bolla, Michel ;
van Poppel, Hein ;
Tombal, Bertrand ;
Vekemans, Kris ;
Da Pozzo, Luigi ;
de Reijke, Theo M. ;
Verbaeys, Antony ;
Bosset, Jean-Francois ;
van Velthoven, Roland ;
Colombel, Marc ;
van de Beek, Cees ;
Verhagen, Paul ;
van den Bergh, Alphonsus ;
Sternberg, Cora ;
Gasser, Thomas ;
van Tienhoven, Geertjan ;
Scalliet, Pierre ;
Haustermans, Karin ;
Collette, Laurence .
LANCET, 2012, 380 (9858) :2018-2027
[3]   Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes [J].
Cookson, Michael S. ;
Aus, Gunnar ;
Burnett, Arthur L. ;
Canby-Hagino, Edith D. ;
D'Amico, Anthony V. ;
Dmochowski, Roger R. ;
Eton, David T. ;
Forman, Jeffrey D. ;
Goldenberg, S. Larry ;
Hernandez, Javier ;
Higano, Celestia S. ;
Kraus, Stephen R. ;
Moul, Judd W. ;
Tangen, Catherine ;
Thrasher, J. Brantley ;
Thompson, Ian .
JOURNAL OF UROLOGY, 2007, 177 (02) :540-545
[4]   Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients? [J].
de la Taille, A ;
Rubin, MA ;
Buttyan, R ;
Olsson, CA ;
Bagiella, E ;
Burchardt, M ;
Wellisch, OM ;
Katz, AE .
EUROPEAN UROLOGY, 2000, 38 (01) :79-84
[5]   Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer [J].
Dillioglugil, O ;
Leibman, BD ;
Kattan, MW ;
SealeHawkins, C ;
Wheeler, TM ;
Scardino, PT .
UROLOGY, 1997, 50 (01) :93-99
[6]   Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality [J].
Freedland, Stephen J. ;
Humphreys, Elizabeth B. ;
Mangold, Leslie A. ;
Eisenberger, Mario ;
Partin, Alan W. .
JOURNAL OF UROLOGY, 2006, 176 (04) :1404-1408
[7]   Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes [J].
Galiabovitch, Elena ;
Hovens, Christopher M. ;
Peters, Justin S. ;
Costello, Anthony J. ;
Battye, Shane ;
Norden, Sam ;
Ryan, Andrew ;
Corcoran, Niall M. .
BJU INTERNATIONAL, 2017, 119 (04) :567-572
[8]   Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer [J].
Han, M ;
Partin, AW ;
Zahurak, M ;
Piantadosi, S ;
Epstein, JI ;
Walsh, PC .
JOURNAL OF UROLOGY, 2003, 169 (02) :517-523
[9]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[10]  
2-4